Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: Positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells

Blood

Volumn 87, Issue 4, 1996, Pages 1625-1634

  Lemoli, Roberto M ^a,b   Fortuna, Alessandra ^a   Motta, Maria Rosa ^a   Rizzi, Simonetta ^a   Giudice, Valeria ^a   Nannetti, Anna ^a   Martinelli, Giovanni ^a   Cavo, Michele ^a   Amabile, Marilina ^a   Mangianti, Serena ^a   Fogli, Miriam ^a   Conte, Roberto ^a   Tura, Sante ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Institute of Haematology and Medical Oncology 'L and A Seragnoli'   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BUSULFAN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; AUTOGRAFT; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW PURGING; CELL TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CYTAPHERESIS; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MALE; MULTIPLE MYELOMA; PERIPHERAL CIRCULATION; PLASMA CELL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; WHOLE BODY RADIATION;

ADULT; ANTIGENS, CD34; BASE SEQUENCE; BLOOD COMPONENT REMOVAL; CELL SEPARATION; CYTOPLASM; DNA PRIMERS; FEMALE; GAMMA RAYS; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOGLOBULINS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIPLE MYELOMA; PLASMA CELLS; WHOLE-BODY IRRADIATION;

EID: 0030022520     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.4.1625.bloodjournal8741625     Document Type: Article

References (51)

1. Barlogie B, Epstein J, Salvanayagam P, Alexanian R: Plasma cell myeloma: New biological insights and advances in therapy. Blood 73:865, 1989
2. Jagannath S, Barlogie B, Dicke Ka, Alexanian R, Zagars G, Cheson B, LeMaistre FC, Smallwood L, Pruitt K, Dixon DO: Autologous bone marrow transplantation in multiple myeloma: Identification of prognostic factors. Blood 76:1860, 1990
3. Harousseau JM, Milpied N, Laporte JP, Collombat P, Facon T, Tigaud JD, Casassus P, Guilhot F, Ifhra N, Gandhour C: Double intensive therapy in high risk multiple myeloma. Blood 79:2827, 1992
4. Cunningham D, Paz-Ares L, Milan S, Powles R, Nicolson M, Hickish T, Selby P, Treleavan J, Viner C, Malpas J, Slevin M, Findlay M, Raymond J, Gore ME: High-dose mc1phalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma. J Clin Oncol 12:759, 1994
5. Fermand JP, Chevert S, Ravaud P, Divine M, Leblond V, Dreyfus F, Mariette X, Brouet JC: High dose chemoradiotherapy with autologous blood stem cell transplantation in multiple myeloma. Results of a phase II trial involving 63 patients. Blood 82:2005, 1993
6. Anderson KC, Andersen J, Soeffer R, Freedman AS, Rabinowe SM, Robertson MJ, Spector N, Blake K, Murray C, Freeman A, Coral F, Marcus KC, Mauch P, Nadler LM, Ritz J: Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma. Blood 82:2568, 1993
7. Vesole DH, Barlogie B, Jagannath S, Cheson B, Tricot G, Alexanian R, Crowley J: High-dose therapy for refractory multiple myeloma: Improved prognosis with better supportive care and double transplant. Blood 84:950, 1994
8. Attal M, Harousseau JL, Stoppa AM, Sotto JL, Fuzibet G, Rossi JF, Casassus P, Thyss A, Maisonneuve H, Facon T, Ifrah N, Payen C, Bataille R: High-dose therapy in multiple myeloma: A prospective randomized study of the "Intergroupe francais du myelome" (IFM). Blood 84:386a, 1994 (abstr, suppl 1)
9. Cavo M, Benni M, Cirio TM, Gozzetti A, Tura S: Allogeneic bone marrow transplantation for the treatment of multiple myeloma. An overview of published reports. Stem Cells 13:126, 1995 (suppl 2)
10. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J, French Anderson W, Ihle JN: Gene-marking to trace the origin of relapse agter autologous bone-marrow transplantation. Lancet 341:85, 1993
11. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83:3068, 1994
12. To LB: Is our current strategy in manipulating hemopoiesis in autologous transplantation correct? Stem Cells 11:283, 1993
13. Berenson J, Wong R, Kim K, Brown N, Lichstentein A: Evidence of peripheral blood B lymphocyte but not T lymphocyte involvement in multiple myeloma. Blood 70:1550, 1987
14. Pilarski LM, Jensen GS: Monoclonal circulating B cells in multiple myeloma: A continuosly differentiating possibly invasive population as denned by expression of CD45 isoforms and adhesion molecules. Hematol Oncol Clin North Am 6:297, 1992
15. Bergui L, Schena M, Gaidano GL, Riva M, Caligaris-Cappio F: Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma. J Exp Med 170:613, 1989
16. Pilarski LM, Belch AR: Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma. Blood 83:724, 1994
17. Chronic Leukemia-Myeloma Task force, National Cancer Institute: Proposed guidelines for protocol studies-II. Plasma cell myeloma. Cancer Chemother Rep (part 3) 4:145, 1973
18. Gianni AM, Bregni M, Stern A, Siena S, Tarella C, Pileri A, Bonadonna G: Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 2:580, 1989
19. Benini C, Bandini G, Motta MR, Belardinelli AR, Calori E, Rizzi S, Martinelli G, Rosti G, Trabetti E, Pignatti P, Tura S: Donor origin of hematopoiesis after a case of allogeneic transplantation with cryopreserved marrow. Haematologica 78:414, 1993
20. Lemoli RM, Gasparetto C, Scheinberg DA, Moore MAS, Clarkson BD, Gulati SC: Autologous bone marrow transplantation in acute myelogenous leukemia: In vitro treatment with myeloidspecific monoclonal antibodies and drugs in combination. Blood 77:829, 1991
21. + peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain. Blood 85:436, 1995
22. Lemoli RM, Fortuna A, Grande A, Gamberi B, Bonsi L, Fogli M, Amabile M, Cavo M, Ferrari S, Tura S: Expression and functional role of c-kit ligand (SCF) in human multiple myeloma. Br J Haematol 88:760, 1994
23. Visani G, Lemoli RM, Dinota A, Galieni P, Gobbi M, Cavo M, Tura S: Evidence that long-term bone marrow culture of patients with multiple myeloma favours normal hemopoietic proliferation. Transplantation 48:1026, 1989
24. Shpall EJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M, Myers SE, Hami L, Taffs S, Heimfeld S, Hallagan J, Berenson RJ: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-posilive peripherai-blood progenitors and growth factors on engraftment. J Clin Oncol 12:28, 1994
25. Brisco MJ, Tan LW, Orsborn AM, Morley AA: Development of a higly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population. Br J Haematol 75:163, 1990
26. Martinelli G, Buzzi M, Zaccaria A, Mantovani V, Farabegoli P, Calori E, Bandini G, Bragliani M, Barboni P, Panzica G, Tura S: New strategies for selection of unrelated bone marrow donors. Bone Marrow Transplant 11:31, 1993
27. Tomlinson IM, Walter G, Marks JD, Llewelyn MB, Winter G: The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol 227:776, 1992
28. Ravetech JV, Siebenlist U, Korsmeyer S, Waldman T, Leder P: Structure of the human immunoglobulin locus: Characterisation of embrionic and rearranged J and D genes. Cell 27:583, 1981
29. Kwok S, Higuchi R: Avoiding false positives with PCR. Nature 339:237, 1989
30. Ross AA, Cooper BW, Lazarus HM, Mackay W, Moss TJ, Ciobanu N, Talmann MS, Kennedy JM, Davidson NE, Sweet D, Winter C, Akard L, Jansen J, Copelan E, Meagher RC, Herzig RH, Klumpp TR, Kahn DG, Warner NE: Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay technique. Blood 82:2605, 1993
31. Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R, Kanz L: Mobilization of tumor cells and hematopoietic progenitor cells into peripheral lood of patients with solid tumors. Blood 83:636, 1994
32. + stem cells do not contain clonal myeloma cells. Blood 86:381, 1995
33. Corradini P, Voena C, Astolfi M, Ladetto M, Tarella C, Boccadoro M, Pileri A: High-dose sequential chemoradiotherapy in multiple myeloma: Residual tumor cells are detectable in bone marrow and peripheral blood harvests and after autografting. Blood 85:1596, 1995
34. Gobbi M, Cavo M, Tazzari PL, Dinota A, Tassi C, Bontadini A, Albertazzi L, Miggiano MC, Rizzi S, Rosti G, Bolognesi A, Stirpe F, Tura S: Autotogous bone marrow transplantation with immunotoxin-purged marrow for advanced multiple myeloma. Eur J Haematol 43:176, 1989 (suppl 51)
35. Strauss LC, Rowley SD, Larussa VF, Sharkis SJ, Stuart RK, Civin CI: Antigenic analysis of hematopoiesis. V. Characterization of MY 10 antigen expression by normal lymphohematopoietic progenitor cells. Exp Hematol 14:878, 1986
36. Andrews RG, Singer JW, Bernstein ID: Monoclonal antibody 12.8 recognizes a 115-KD molecule present on both unipotent and multipotent hematopoietic colony forming cells and their precursors. Blood 67:842, 1986
37. Andrews RG, Singer JW, Bernstein ID: Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med 169:1721, 1989
38. Berenson RJ, Bensinger WI, Andrews RG, Kalamasz D, Hill R, Bernstein ID: Hematopoietic stem cell transplants, in Gale RP, Golde DW (eds): Recent Advances in Leukemia and Lymphoma, UCLA Symposia on Molecular and Cellular Biology, New Series (vol 61). New York, NY, Liss, 1987, p 527
39. Watt SM, Karhi K, Gatter K, Furley AJW, Katz FE, Healy LE, Altass LJ, Bradley NJ, Sutherland DR, Levinsky R, Greaves MF: Distribution and epitope analysis of the cell membrane glycoprotein (HPCA-1) associated with human hematopoietic progenitor cells. Leukemia 1:417, 1988
40. Takishita M, Kosaka M, Goto T, Saito S: Cellular origin and extent of clonal involvement in multiple myeloma: Genetic and phenotypic studies. Br J Haematol 87:735, 1994
41. Sahota S, Hamblin T, Oscier DG, Stevenson FK: Assessment of the role of clonogenic B lymphocytes in the pathogenesis of multiple myeloma. Leukemia 8:1285, 1994
42. Vescio RA, Hong CH, Cao J, Kim A, Schiller GJ, Lichtenstein AK, Berenson RJ, Berenson JR: The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma. Blood 84:3283, 1994
43. + peripheral blood progenitor cells after high dose chemotherapy for patients with advanced multiple myeloma. Blood 86:390, 1995
44. + marrow cells in patients with breast cancer or neuroblastoma. Blood 77:1717, 1991
45. + cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high dose VP 16, ifosfamide, carboplatin, and epirubicin. Blood 84:1421, 1994
46. + bone marrow progenitor cells in patients with non-Hodgkin' s lymphoma. Blood 85:1647, 1995
47. Klein B, Zhang XG, Lu ZY, Bataille R: Interleukin-6 in human multiple myeloma. Blood 85:863, 1995
48. Witzig TE, Kyle RA, O'Fallon WM, Greipp PR: Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma. Br J Haematol 87:266, 1994
49. Lemoli RM, Gobbi M, Tazzari PL, Tassi C, Dinota A, Visani G, Grassi G, Mazza P, Cavo M, Tura S: Bone marrow purging for multiple myeloma by avidin-biotin immunoabsorption. Transplantation 47:385, 1989
50. - lymphoid cells and the purging efficiency is increased by anti-CD2 and anti-CD30 immunotoxins. Bone Marrow Transplant 13:465, 1994
51. + hematopoietic cells using an immunoaffinity column results in T-cell depletion equivalent to elutriation. Exp Hematol 23:320, 1995